What is Aumapharma?
Aumapharma is a US-based startup dedicated to advancing treatments for respiratory diseases and therapeutics. The company's core operations involve providing expert consultancy services to the pharmaceutical industry and academic research institutions. Furthermore, Aumapharma actively identifies and pursues the clinical development of drug opportunities aimed at addressing critical unmet medical needs within the pulmonary disease landscape. Their strategic focus is on enhancing patient outcomes through innovative therapeutic solutions.
How much funding has Aumapharma raised?
Aumapharma has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Aumapharma
PPP
Public-Private Partnership
What's next for Aumapharma?
With the recent influx of substantial expansion capital, Aumapharma is poised for significant growth and development. The company's strategic objective to bring novel treatments to patients suffering from pulmonary diseases will likely be accelerated. This financing is expected to fuel further research and development initiatives, potentially leading to expanded clinical trials and the progression of their drug pipeline. Aumapharma's commitment to leveraging its specialized expertise in respiratory medicine positions it for impactful contributions to patient care and the broader biopharmaceutical industry.
See full Aumapharma company page
